Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Genome-wide RNA pol II initiation and pausing in neural progenitors of the rat.

Scheidegger A, Dunn CJ, Samarakkody A, Koney NK, Perley D, Saha RN, Nechaev S.

BMC Genomics. 2019 Jun 11;20(1):477. doi: 10.1186/s12864-019-5829-4.

2.

Short-Segment Fixation With Percutaneous Pedicle Screws in the Treatment of Unstable Thoracolumbar Vertebral Body Fractures.

Sahai N, Faloon MJ, Dunn CJ, Issa K, Sinha K, Hwang KS, Emami A.

Orthopedics. 2018 Nov 1;41(6):e802-e806. doi: 10.3928/01477447-20180912-05. Epub 2018 Sep 18.

PMID:
30222793
3.

Risk Factors for Pseudarthrosis in Minimally-Invasive Transforaminal Lumbar Interbody Fusion.

Emami A, Faloon M, Sahai N, Dunn CJ, Issa K, Thibaudeau D, Sinha K, Hwang KS.

Asian Spine J. 2018 Oct;12(5):830-838. doi: 10.31616/asj.2018.12.5.830. Epub 2018 Sep 10.

4.

Reply to the Letter to the Editor: Incidence of Neuraxial Abnormalities Is Approximately 8% Among Patients With Adolescent Idiopathic Scoliosis: A Meta-analysis.

Faloon M, Sahai N, Pierce TP, Dunn CJ, Sinha K, Hwang KS, Emami A.

Clin Orthop Relat Res. 2018 Aug;476(8):1688. doi: 10.1097/CORR.0000000000000342. No abstract available.

PMID:
29846203
5.

Persistent 6-OH-BDE-47 exposure impairs functional neuronal maturation and alters expression of neurodevelopmentally-relevant chromatin remodelers.

Poston RG, Dunn CJ, Sarkar P, Saha RN.

Environ Epigenet. 2018 Jan 12;4(1):dvx020. doi: 10.1093/eep/dvx020. eCollection 2018 Jan.

6.

Severe fire weather and intensive forest management increase fire severity in a multi-ownership landscape.

Zald HSJ, Dunn CJ.

Ecol Appl. 2018 Jun;28(4):1068-1080. doi: 10.1002/eap.1710. Epub 2018 Apr 26.

PMID:
29698575
7.

Different Neuronal Activity Patterns Induce Different Gene Expression Programs.

Tyssowski KM, DeStefino NR, Cho JH, Dunn CJ, Poston RG, Carty CE, Jones RD, Chang SM, Romeo P, Wurzelmann MK, Ward JM, Andermann ML, Saha RN, Dudek SM, Gray JM.

Neuron. 2018 May 2;98(3):530-546.e11. doi: 10.1016/j.neuron.2018.04.001. Epub 2018 Apr 19.

8.

Incidence of Neuraxial Abnormalities Is Approximately 8% Among Patients With Adolescent Idiopathic Scoliosis: A Meta-analysis.

Faloon M, Sahai N, Pierce TP, Dunn CJ, Sinha K, Hwang KS, Emami A.

Clin Orthop Relat Res. 2018 Jul;476(7):1506-1513. doi: 10.1007/s11999.0000000000000196.

PMID:
29470234
9.

Silk provides a new avenue for third generation biosensors: Sensitive, selective and stable electrochemical detection of nitric oxide.

Musameh MM, Dunn CJ, Uddin MH, Sutherland TD, Rapson TD.

Biosens Bioelectron. 2018 Apr 30;103:26-31. doi: 10.1016/j.bios.2017.12.019. Epub 2017 Dec 15.

PMID:
29277011
10.

Design of silk proteins with increased heme binding capacity and fabrication of silk-heme materials.

Rapson TD, Liu JW, Sriskantha A, Musameh M, Dunn CJ, Church JS, Woodhead A, Warden AC, Riley MJ, Harmer JR, Noble CJ, Sutherland TD.

J Inorg Biochem. 2017 Dec;177:219-227. doi: 10.1016/j.jinorgbio.2017.08.031. Epub 2017 Sep 4.

PMID:
29031180
11.

Histone Hypervariants H2A.Z.1 and H2A.Z.2 Play Independent and Context-Specific Roles in Neuronal Activity-Induced Transcription of Arc/Arg3.1 and Other Immediate Early Genes.

Dunn CJ, Sarkar P, Bailey ER, Farris S, Zhao M, Ward JM, Dudek SM, Saha RN.

eNeuro. 2017 Aug 24;4(4). pii: ENEURO.0040-17.2017. doi: 10.1523/ENEURO.0040-17.2017. eCollection 2017 Jul-Aug.

12.

Low energy chronic traumatic spondylolisthesis of the axis.

Dunn CJ, Mease S, Issa K, Sinha K, Emami A.

Eur Spine J. 2017 Jul 21. doi: 10.1007/s00586-017-5206-4. [Epub ahead of print]

PMID:
28733720
13.

Theoretical and Experimental Investigation of Microphase Separation in Mixed Thiol Monolayers on Silver Nanoparticles.

Merz SN, Farrell ZJ, Dunn CJ, Swanson RJ, Egorov SA, Green DL.

ACS Nano. 2016 Nov 22;10(11):9871-9878. Epub 2016 Oct 18.

PMID:
27744676
14.

Deficits in episodic memory retrieval reveal impaired default mode network connectivity in amnestic mild cognitive impairment.

Dunn CJ, Duffy SL, Hickie IB, Lagopoulos J, Lewis SJ, Naismith SL, Shine JM.

Neuroimage Clin. 2014 Feb 27;4:473-80. doi: 10.1016/j.nicl.2014.02.010. eCollection 2014.

15.
16.

Aeromedical evacuation of patients with pneumocephalus: outcomes in 21 cases.

Donovan DJ, Iskandar JI, Dunn CJ, King JA.

Aviat Space Environ Med. 2008 Jan;79(1):30-5.

PMID:
18225775
17.

Recombinant Factor VIIa.

Dunn CJ, Spencer CM.

BioDrugs. 1999 Jul;12(1):71-7.

PMID:
18031164
19.

Study on spontaneous cerebrospinal fluid rhinorrhoea: its aetiology and management.

Dunn CJ, Alaani A, Johnson AP.

J Laryngol Otol. 2005 Jan;119(1):12-5.

PMID:
15807955
20.

Oxaliplatin: in operable colorectal cancer.

Keam SJ, Dunn CJ, Figgitt DP.

Drugs. 2005;65(1):89-96; discussion 97-8. Review.

PMID:
15610052
21.
22.
23.

Insulin glargine: an updated review of its use in the management of diabetes mellitus.

Dunn CJ, Plosker GL, Keating GM, McKeage K, Scott LJ.

Drugs. 2003;63(16):1743-78. Review.

PMID:
12904090
24.

Pharmacokinetic properties, induction of interferon, and efficacy of selected 5-halo-6-phenyl pyrimidinones, bropirimine analogues, in a model of severe experimental autoimmune encephalomyelitis.

Vroegop SM, Chapman DL, Decker DE, Galinet LA, Brideau RJ, Ready KA, Dunn CJ, Buxser SE.

Int J Immunopharmacol. 1999 Oct;21(10):647-62.

PMID:
12609460
25.

Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.

Dunn CJ, Plosker GL.

Pharmacoeconomics. 2002;20(14):989-1025. Review.

PMID:
12403639
26.

Esomeprazole: a review of its use in the management of acid-related disorders.

Scott LJ, Dunn CJ, Mallarkey G, Sharpe M.

Drugs. 2002;62(10):1503-38. Review.

PMID:
12093317
27.

Esomeprazole: a review of its use in the management of acid-related disorders in the US.

Scott LJ, Dunn CJ, Mallarkey G, Sharpe M.

Drugs. 2002;62(7):1091-118. Erratum in: Drugs 2002;62(15):2183.

PMID:
11985491
28.
29.
30.

Calcipotriol ointment. A review of its use in the management of psoriasis.

Scott LJ, Dunn CJ, Goa KL.

Am J Clin Dermatol. 2001;2(2):95-120. Review.

PMID:
11705309
31.

Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease.

Dooley M, Spencer CM, Dunn CJ.

Drugs. 2001;61(9):1351-78. Review.

PMID:
11511027
32.
33.

Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.

Dunn CJ, Goa KL.

Drugs. 2001;61(2):285-315. Review.

PMID:
11270943
34.

Evaluation of multiphase implants for repair of focal osteochondral defects in goats.

Niederauer GG, Slivka MA, Leatherbury NC, Korvick DL, Harroff HH, Ehler WC, Dunn CJ, Kieswetter K.

Biomaterials. 2000 Dec;21(24):2561-74.

PMID:
11071606
35.

Nateglinide.

Dunn CJ, Faulds D.

Drugs. 2000 Sep;60(3):607-615; discussion 616-7. Review.

PMID:
11030470
36.

Pioglitazone.

Gillies PS, Dunn CJ.

Drugs. 2000 Aug;60(2):333-43; discussion 344-5. Review.

PMID:
10983737
37.

Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic disease.

Dunn CJ, Jarvis B.

Drugs. 2000 Jul;60(1):203-37. Review. Erratum in: Drugs 2000 Oct;60(4):719.

PMID:
10929935
39.

Abciximab. A pharmacoeconomic review of its use in percutaneous coronary revascularisation.

Dunn CJ, Foster RH.

Pharmacoeconomics. 1999 Dec;16(6):711-41. Review.

PMID:
10724797
40.

Fibrin sealant: a review of its use in surgery and endoscopy.

Dunn CJ, Goa KL.

Drugs. 1999 Nov;58(5):863-86. Review.

PMID:
10595866
41.

Zanamivir: a review of its use in influenza.

Dunn CJ, Goa KL.

Drugs. 1999 Oct;58(4):761-84. Review.

PMID:
10551442
42.

Oxidation of deoxy myoglobin by [Fe(CN)6]3-.

Dunn CJ, Rohlfs RJ, Fee JA, Saltman P.

J Inorg Biochem. 1999 Jul 15;75(4):241-4.

PMID:
10499287
43.

Acceleration and increased severity of collagen-induced arthritis in P-selectin mutant mice.

Bullard DC, Mobley JM, Justen JM, Sly LM, Chosay JG, Dunn CJ, Lindsey JR, Beaudet AL, Staite ND.

J Immunol. 1999 Sep 1;163(5):2844-9.

44.

Glycemic control and cardiovascular disease in type 2 diabetes: a review.

Wild SH, Dunn CJ, McKeigue PM, Comte S.

Diabetes Metab Res Rev. 1999 May-Jun;15(3):197-204. Review.

PMID:
10441042
45.

Pharmacology of the biological response modifier bropirimine (PNU-54461) on experimental autoimmune encephalomyelitis (EAE) in mice.

Vroegop SM, Chapman DL, Galinet LA, Decker DE, Ready KA, Brideau RJ, Dunn CJ, Buxser SE.

Int J Immunopharmacol. 1999 Jun;21(6):391-409.

PMID:
10405874
46.

Tranexamic acid: a review of its use in surgery and other indications.

Dunn CJ, Goa KL.

Drugs. 1999 Jun;57(6):1005-32. Review.

PMID:
10400410
47.

Anti-inflammatory/antiarthritic ketonic bisphosphonic acid esters.

Schlachter ST, Galinet LA, Shields SK, Aspar DG, Dunn CJ, Staite ND, Nugent RA.

Bioorg Med Chem Lett. 1998 May 5;8(9):1093-6.

PMID:
9871714
48.

Role of PECAM-1 (CD31) in neutrophil transmigration in murine models of liver and peritoneal inflammation.

Chosay JG, Fisher MA, Farhood A, Ready KA, Dunn CJ, Jaeschke H.

Am J Physiol. 1998 Apr;274(4):G776-82. doi: 10.1152/ajpgi.1998.274.4.G776.

PMID:
9575861
49.

Involvement of intercellular adhesion molecule-1 in the antigen-induced infiltration of eosinophils and lymphocytes into the airways in a murine model of pulmonary inflammation.

Chin JE, Winterrowd GE, Hatfield CA, Brashler JR, Griffin RL, Vonderfecht SL, Kolbasa KP, Fidler SF, Shull KL, Krzesicki RF, Ready KA, Dunn CJ, Sly LM, Staite ND, Richards IM.

Am J Respir Cell Mol Biol. 1998 Feb;18(2):158-67.

PMID:
9476902
50.

Supplemental Content

Support Center